05/14/2026

What Is Breast Implant Associated Illness (BII)?

Breast augmentation in Dubai is one of the most commonly performed cosmetic surgeries in the world – and for the vast majority of patients, implants deliver safe, long-lasting results without complications.

However, a growing number of patients with breast implants are reporting a wide range of unexplained, systemic symptoms that they believe are directly connected to their implants. What is breast implant associated illness? This collection of symptoms is known as breast implant illness (BII) – also referred to as breast implant associated illness in clinical and regulatory literature, silicone breast implant illness, or Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA syndrome).

As a specialist in breast surgery and implant complications, Dr Rory McGoldrick takes every patient’s concerns seriously. If you believe your breast implants may be affecting your health, you deserve to be heard, properly assessed, and supported with evidence-based options.

What Is Breast Implant Associated Illness?

What is breast implant associated illness? It refers to a wide range of physical, cognitive, and systemic symptoms that can develop in people who have any type of breast implant. Also known as breast implant illness (BII), symptoms may begin shortly after surgery or develop gradually over months or even years.

Importantly, BII is not currently recognised as an official medical diagnosis – because the scientific and medical community is still actively researching its causes and mechanisms. However, this is beginning to change. In 2021, the U.S. Food and Drug Administration (FDA) began requiring breast implant manufacturers to include information about systemic symptoms – those affecting the whole body – in mandatory warning labels on breast implant packaging and in patient decision checklists given before surgery. This landmark regulatory change was a direct recognition of what breast implant associated illness means for patients globally, and marked a significant shift in how health authorities view the reality of breast implant associated illness symptoms.

Crucially, patients experiencing breast implant illness symptoms have reported more than 50 different symptoms affecting their musculoskeletal system, cognitive function, and overall health – making BII one of the most wide-ranging and underdiagnosed conditions in cosmetic surgery.

Breast Implant Illness Symptoms

Symptoms of breast implant illness can vary significantly from person to person, and no two patients present identically. Breast implant associated illness symptoms can affect people with any implant type – silicone gel-filled, saline-filled, smooth, textured, round, or teardrop-shaped – and can develop whether the implants are intact or have ruptured.

Musculoskeletal Symptoms

  • Joint pain and stiffness
  • Muscle pain and weakness
  • Body aches and widespread musculoskeletal discomfort
  • Fibromyalgia-like pain

Cognitive Symptoms

  • Brain fog – difficulty thinking clearly, processing information, or making decisions
  • Memory problems and forgetfulness
  • Difficulty concentrating
  • Anxiety and depression
  • Sleep disturbances and chronic insomnia
  • Headaches

Systemic Symptoms

  • Chronic fatigue – debilitating tiredness not relieved by rest
  • Hair loss – shedding, thinning, or bald patches
  • Skin rashes, dryness, sensitivity, or unexplained breakouts
  • Dry eyes and dry mouth
  • Gastrointestinal problems – bloating, nausea, food sensitivities
  • Breathing difficulties
  • Hormonal imbalances and thyroid dysfunction
  • Vision changes – blurred vision or sensitivity to light
  • Unexplained weight changes
  • New or worsening autoimmune condition symptoms

The breadth of these breast implant illness symptoms is precisely why diagnosis is so challenging. Many patients spend years pursuing evaluations across multiple specialities – rheumatology, neurology, endocrinology, dermatology – before a connection to their breast implants is considered.

What Causes Breast Implant Illness?

What causes breast implant illness? – and more specifically, what is breast implant associated illness at a biological level? The honest answer is that researchers have not yet identified a single definitive cause. However, several theories have emerged from ongoing clinical research:

Autoimmune and inflammatory response: The most widely supported theory is that BII represents a form of chronic, low-grade immune reaction to materials in the breast implant – particularly silicone. The body may recognise the implant as a foreign object and mount a persistent inflammatory response, triggering systemic symptoms throughout the body.

Biofilm formation: A thin layer of bacteria – known as a biofilm – can form on the implant surface. This biofilm may trigger a chronic, subclinical infection and inflammatory response that over time affects multiple body systems.

Silicone particle migration: In some cases, microscopic silicone particles from implant shells – even without a full rupture – may migrate to surrounding tissue or lymph nodes, provoking immune responses across the body.

ASIA Syndrome (Autoimmune/Inflammatory Syndrome Induced by Adjuvants): Some clinical researchers classify breast implant associated illness as a subset of ASIA syndrome – a broader immune condition triggered by adjuvants (external materials that stimulate the immune system). This framework helps explain why some patients are susceptible to breast implant illness while the majority are not.

Genetic susceptibility: Individual immune system profiles may play a significant role. Patients with a personal or family history of autoimmune conditions – such as lupus, rheumatoid arthritis, or Sjögren’s syndrome – may be at higher risk of developing breast implants and autoimmune disease overlap.

Breast Implants and Autoimmune Disease

One of the most frequently asked questions from patients is whether there is a proven link between breast implants and autoimmune disease.

Several studies have identified associations – particularly between textured implants and higher rates of inflammatory symptoms. A 2022 study published in Nature Scientific Reports found that patients who reported breast implant illness symptoms demonstrated significant improvement after explant surgery, suggesting a direct relationship between the implant and their systemic health.

However, it is important to distinguish between an association and a proven causal mechanism. Not all patients with breast implants develop autoimmune symptoms – and not all patients who develop systemic illness after implants have BII. The individual immune response appears to be the key variable, which is why thorough evaluation by an experienced specialist is essential.

Breast implant complications related to autoimmune overlap may present similarly to:

  • Lupus (systemic lupus erythematosus)
  • Rheumatoid arthritis
  • Scleroderma
  • Sjögren’s syndrome
  • Fibromyalgia
  • Hashimoto’s thyroiditis / hypothyroidism
  • Lyme disease
  • Chronic fatigue syndrome

This overlap makes breast implant illness diagnosis particularly complex – and is why a systematic exclusion approach is necessary before attributing symptoms to breast implant associated illness.

How Is Breast Implant Illness Diagnosed?

Patients searching for answers to what is breast implant associated illness often arrive at Dr Rory’s clinic after years of unexplained symptoms and inconclusive tests across multiple specialities. Breast implant illness diagnosis is challenging because there are currently no specific diagnostic tests or widely accepted diagnostic criteria for BII. It is diagnosed primarily by exclusion – meaning all other conditions that could explain the symptoms must first be ruled out.

Dr Rory’s evaluation approach for patients presenting with possible breast implant associated illness symptoms includes:

Detailed symptom history: A comprehensive review of when symptoms began, their progression, and their relationship to the timing of implant surgery.

Review of implant history: Implant type, manufacturer, age, placement technique, and any known issues such as rupture or capsular contracture.

Targeted investigations: Depending on the symptom presentation, blood tests may be ordered to assess inflammatory markers (CRP, ESR), thyroid function, autoimmune antibodies (ANA, anti-dsDNA), full blood count, and hormonal panels.

Specialist referrals where indicated: Rheumatology for joint and immune symptoms, endocrinology for hormone and thyroid concerns, dermatology for skin presentations, and neurology for cognitive and neurological symptoms.

Imaging: Ultrasound or MRI of the breast implants to assess integrity and rule out breast implant rupture or significant breast implant rippling.

If no alternative diagnosis is found and symptoms persist, implant removal becomes the primary treatment option to both confirm and address breast implant illness.

Breast Implant Illness Treatment

The most effective and evidence-supported breast implant illness treatment is surgical removal of the implants – a procedure known as explant surgery.

Explant Surgery (Implant Removal)

During explant surgery, Dr Rory removes the breast implants. Depending on the patient’s case, this may be combined with capsulectomy – removal of the surrounding scar tissue capsule – which many BII specialists believe is important for maximising symptom resolution and addressing breast implant associated illness comprehensively.

En-Bloc Capsulectomy

En-bloc capsulectomy is a more advanced surgical technique in which the implant and its surrounding capsule are removed as a single, intact unit – without being opened or cut into. This approach is favoured in breast implant illness treatment cases because it minimises the risk of releasing inflammatory material into the surgical field. It requires specialist surgical expertise and experience.

Clinical evidence supports the effectiveness of implant removal for breast implant illness. Multiple studies – including the 2022 Nature Scientific Reports paper – have shown significant improvement in breast implant illness symptoms following explant surgery. A study from the American Society of Aesthetic Plastic Surgery found symptom improvement in many patients within three months of surgery.

Important note: Plastic surgeons generally do not recommend replacing BII-associated implants with new ones, as breast implant associated illness symptoms may recur. However, this is a decision made on an individual basis during consultation.

Managing Autoimmune Conditions

If investigations identify an underlying autoimmune condition alongside breast implant illness symptoms, Dr Rory will refer the patient to the appropriate specialist for targeted treatment in parallel with or following explant surgery.

Recovery After Explant Surgery

Recovery from explant surgery – particularly when combined with capsulectomy – follows a similar timeline to other breast revision procedures:

  • Days 1–5: Rest at home. Some swelling, bruising, and chest tightness is normal.
  • Week 1–2: Light activity only. Most patients can return to desk-based work.
  • Weeks 3–6: Progressive return to normal activity. Avoid strenuous exercise and heavy lifting.
  • Weeks 4–12: Many patients begin to notice improvement in breast implant illness symptoms – including energy levels, mental clarity, and joint comfort – during this period.
  • 3–6 months: Full aesthetic and physical recovery. Final implant cavity healing complete.

It is important to have realistic expectations: some breast implant illness symptoms resolve quickly, others improve gradually, and in some patients – particularly those with confirmed underlying autoimmune conditions – symptoms may persist and require separate management.

BII vs BIA-ALCL: What Is the Difference?

It is important not to confuse breast implant illness (BII) with BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma) – these are two entirely distinct conditions.

Name

BII / Breast Implant Associated Illness

BIA-ALCL

Nature

Systemic inflammatory/immune syndrome

Rare immune system cancer (lymphoma)

Implant type

Any implant type

Primarily textured implants

Symptoms

Fatigue, brain fog, joint pain, rashes, hair loss

Swelling, fluid around implant, lump

Official diagnosis

Not yet – in progress

Yes – recognised cancer diagnosis

Treatment

Explant surgery ± capsulectomy

Prompt surgical removal of implant + capsule

If you experience sudden, unexplained swelling or fluid accumulation around an implant – particularly years after surgery – seek an urgent evaluation, as this may indicate BIA-ALCL rather than breast implant associated illness.

Expert Care for Breast Implant Illness in Dubai

If you have been searching for answers to what is breast implant associated illness and believe your implants may be connected to symptoms you are experiencing, you deserve to be taken seriously.

Dr Rory McGoldrick is a British-trained plastic surgeon based in Dubai, with specialist experience in complex breast revision surgery – including explant surgery, en-bloc capsulectomy, and the comprehensive management of breast implant complications. He takes a thorough, patient-centred approach to every breast implant illness evaluation, ensuring that all possible causes are considered and that each patient receives honest, evidence-based guidance on their options.

Do not delay seeking an evaluation. Early assessment gives you the best options.

Book a consultation with Dr Rory today

FAQ

It is the formal clinical and regulatory term for breast implant illness (BII) – a collection of more than 50 reported systemic symptoms including chronic fatigue, brain fog, joint pain, hair loss, and rashes that some patients develop after receiving breast implants. While not yet officially recognised as a formal medical diagnosis, it is increasingly acknowledged by the FDA and major plastic surgery bodies worldwide.

The most commonly reported breast implant illness symptoms include chronic fatigue, brain fog and memory problems, joint and muscle pain, hair loss, skin rashes, anxiety and depression, dry eyes, gastrointestinal problems, and unexplained hormonal changes.

 Silicone breast implant illness is frequently discussed, but breast implant associated illness symptoms have been reported with all implant types – silicone gel-filled, saline-filled, smooth, textured, round, and teardrop. The type of implant does not appear to be the sole determinant of risk.

There is currently no proven non-surgical breast implant illness treatment. Removing the implants – particularly with capsulectomy – is the treatment most consistently associated with symptom improvement in clinical literature.

Breast implant associated illness symptoms can develop at any point after surgery – some patients notice changes within weeks, while others develop symptoms years or even decades after their original breast augmentation.

Multiple clinical studies show that the majority of patients experience significant improvement in breast implant illness symptoms after explant surgery – with some reporting relief within 30 days. However, outcomes vary, and patients with co-existing autoimmune conditions may need additional treatment.

No. BIA-ALCL is a rare form of lymphoma specifically linked to textured implants, presenting as localised swelling or a lump around the implant. Breast implant illness (BII) – also called breast implant associated illness – is a systemic symptom condition with a different presentation and mechanism. Both are implant complications that require specialist evaluation.

What is breast implant associated illness versus breast implant illness? They refer to the same condition. “Breast implant associated illness” is the more formal clinical and regulatory term used in research and FDA documentation. “Breast implant illness” or “BII” is the widely used patient-facing term. Both describe the same cluster of systemic symptoms linked to breast implants.

Consultation Booking